Structural basis for the action of the drug trametinib at KSR-bound MEKZ.M. Khan, Arvin C. Dar, Arthur Chow et al.|Nature|2020Cited by 172
WNTinib is a multi-kinase inhibitor with specificity against β-catenin mutant hepatocellular carcinomaAlexander Rialdi, Arvin C. Dar, Z.M. Khan et al.|Nature Cancer|2023Cited by 27
Type II Binders Targeting the “GLR-Out” Conformation of the Pseudokinase STRADαRyan H. B. Smith, Arvin C. Dar, Seshat M. Mack et al.|Biochemistry|2021Cited by 7
Integrated computational and <i>Drosophila</i> cancer model platform captures previously unappreciated chemicals perturbing a kinase networkPeter M.U. Ung, Avner Schlessinger, Ross Cagan et al.|bioRxiv (Cold Spring Harbor Laboratory)|2018Cited by 1